Luoyang Molybdenum vs WuXi AppTec
Which is stronger right now? The dated snapshot below answers it with quality, valuation ceiling, risk, and timing — side by side, then the full decision brief.
Two tickers, one decision framework. Instead of vibes, put both names through the same quality → valuation → thesis-breaks → timing process and let the weaker story drop.
Snapshot comparison (2026-08-28)
| 603993.SS | 603259.SS | |
|---|---|---|
| Company | Luoyang Molybdenum | WuXi AppTec |
| Market | 🇨🇳 China A-share | 🇨🇳 China A-share |
| Sector | Metals | CRO |
| Price | ¥19.52 | ¥157.90 |
| Signal | LONG · +176.8% | LONG · +165.8% |
| Total return | +176.8% | +165.8% |
Decide it with the calculator
Run both names through the free intrinsic value calculator — the one with the wider gap between price and ceiling on equal quality usually wins the slot.
See the full decision brief
Run it on live data — free
Stock Chat + Screener preview · 30 monthly AI credits. Real-time scanner across US, Hong Kong, China A-shares, Korea, and India.
FAQ
Luoyang Molybdenum or WuXi AppTec — which is the better buy?
The honest answer comes from the same workflow on both names: quality score, valuation ceiling versus today's price, and which thesis breaks worry you more. The snapshot table above gives the current dated state of each.
How are 603993.SS and 603259.SS different?
Luoyang Molybdenum trades on China A-share (Metals); WuXi AppTec trades on China A-share (CRO). Currency, liquidity, and disclosure regimes differ — the workflow stays identical.
Deeper comparison — Luoyang Molybdenum (603993.SS) vs WuXi AppTec (603259.SS)
Beyond the snapshot above, the real comparison comes from running the same workflow on both companies: score quality, set the valuation ceiling, and write the break conditions for each. The framework stays identical; only the data changes.
| Dimension | 603993.SS | 603259.SS |
|---|---|---|
| Market | 🇨🇳 China A | 🇨🇳 China A |
| Sector | Metals | CRO |
| STM signal | LONG | LONG |
| uPnL | +176.8% | +165.8% |
| Total return | +176.8% | +165.8% |
Use this table as a starting point, not an answer. The decision comes from running the full workflow on both companies — 603993.SS brief · 603259.SS brief — and comparing the outputs side by side.
Get more Balance Labs in your Google results
Add balancelabs.app as a Preferred Source on Google to see our research in Search and AI Overviews.
Cite this page
Balance Labs Research Desk. "Luoyang Molybdenum vs WuXi AppTec" https://balancelabs.app/stocks/compare/603993.ss-vs-603259.ss. Data snapshot: . CC BY 4.0 with attribution.
Ask anything about 603993.SS
Same AI engine as this decision brief — grounded in live tool reports.
30 free credits monthly · no card required · research support, not advice
← All guides · Home · Data snapshot 2026-08-28 · Not investment advice.